Bromazolam powder has no approved medical use and is utilized illicitly to manufacture counterfeit prescription pills or adulterate dangerous street drugs. [1, 2]
According to ISSUP, “Bromazolam is a “designer” benzodiazepine never approved for medical use in any country.”
Market Context and Identification
Bromazolam powder is primarily identified in the illicit drug market, where it has been detected as an active ingredient in counterfeit prescription tablets, particularly those designed to resemble alprazolam. Forensic laboratory analyses indicate that the powder is also found in combination with other illicit substances, such as fentanyl, cocaine, and methamphetamine. [1, 2, 3]
Pharmacological Profile
As a synthetic benzodiazepine, bromazolam acts on the central nervous system to produce effects characteristic of this drug class. These effects include: [1, 2]
- Central nervous system depression and sedation
- Anxiolytic (anxiety-reducing) properties
- Muscle relaxation
- Hypnotic (sleep-inducing) effects [1, 2, 3, 4]
Public Health Risks
Because bromazolam is manufactured in unregulated environments, the purity and concentration of the powder are highly variable, leading to an unpredictable risk profile. A significant hazard associated with the substance is its co-ingestion with opioids like fentanyl or with alcohol. Such combinations markedly increase the risk of severe respiratory depression and fatal overdose. Furthermore, standard opioid reversal agents, such as naloxone, are ineffective against the effects of benzodiazepines, complicating emergency medical responses during an overdose involving bromazolam. Prolonged use can also lead to physical dependence and a severe withdrawal syndrome. [1, 2, 3, 4]
Regulatory Status
In response to increasing detection rates and associated fatalities, the U.S. Drug Enforcement Administration (DEA) placed bromazolam into Schedule I of the Controlled Substances Act under an emergency temporary scheduling order. This classification signifies that the substance has a high potential for abuse and no currently accepted medical use in the United States.
How long does bromazolam stay in your urine?
Bromazolam can be detected in urine for 1 to 3 days after a single use, and up to 7 days (or longer) with regular or heavy use. Refine Recovery
Factors That Affect Detection Time
- Frequency of use: Frequent or chronic use builds up metabolites in the body, extending the detection window.
- Dosage: Higher doses take longer for the body to process and eliminate.
- Metabolism: Individual metabolic rate, age, liver function, and overall health change how fast your body clears substances.
- Test type: Standard immunoassay panels may or may not flag designer benzodiazepines like bromazolam, whereas specialized confirmatory tests (like LC-MS/MS) detect it reliably.
What is bromazepam used to treat?
Bromazepam is a benzodiazepine medication mainly used for the short-term treatment of severe anxiety, panic symptoms, and related emotional distress or insomnia. Drugs.com +1
Primary Medical Uses
- Severe Anxiety and Panic: Prescribed to relieve intense generalized anxiety, nervous tension, and panic states.
- Emotionally Driven Insomnia: Used briefly to help with sleep problems caused by high stress or anxiety.
- Psychosomatic Disorders: Administered to help manage physical symptoms triggered by psychological stress, such as digestive or cardiovascular discomfort.
- Premedication: Sometimes given as a calming agent before minor surgical or medical procedures.
Wikipedia +5
Important Safety Information
- Short-Term Use: Doctors usually prescribe it for only a few weeks because long-term use can lead to physical dependence and tolerance.
Drugs.com +1
- Withdrawal Risks: Stopping the medication abruptly can trigger severe withdrawal effects, so a doctor must supervise a gradual tapering schedule.
Drugs.com
- Availability: Bromazepam is approved and used in various countries (often sold under brand names like Lexotan), but it is not available or approved for use in the United States.